Erika Borlenghi
- Hematology top 2%
- Oncology top 5%
- Public Health, Environmental and Occupational Health top 5%
- Pathology and Forensic Medicine top 5%
- Genetics top 5%
- Co-authors
- Giuseppe RossiChiara CattaneoAlessandra TucciAlessandro ReChiara BottelliSalvatore CasariMonica DreraSamantha Ferrari
- Topics
- Acute Myeloid Leukemia Research (26 papers)Acute Lymphoblastic Leukemia research (20 papers)Chronic Myeloid Leukemia Treatments (15 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Erika Borlenghi
52 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 74
- Hematology 491
- Oncology 462
- Public Health, Environmental and Occupational Health 334
- Pathology and Forensic Medicine 229
- Genetics 216
Countries citing papers authored by Erika Borlenghi
This map shows the geographic impact of Erika Borlenghi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Borlenghi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Borlenghi more than expected).
Fields of papers citing papers by Erika Borlenghi
This network shows the impact of papers produced by Erika Borlenghi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Borlenghi. The network helps show where Erika Borlenghi may publish in the future.
Co-authorship network of co-authors of Erika Borlenghi
This figure shows the co-authorship network connecting the top 25 collaborators of Erika Borlenghi. A scholar is included among the top collaborators of Erika Borlenghi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Borlenghi. Erika Borlenghi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 6 | |
| 3 | 8 | |
| 4 | 2 | |
| 5 | 13 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 20 | |
| 9 | 1 | |
| 10 | 0 | |
| 11 | 1 | |
| 12 | 17 | |
| 13 | 72 | |
| 14 | 24 | |
| 15 | Short-course imatinib (IM) added to chemotherapy improves early but not long-term outcome in adult Ph/BCR-ABL+ acute lymphoblastic leukemia (ALL) : 5-year follow-up results of study NILG-09 | 4 |
| 16 | 102 | |
| 17 | 18 | |
| 18 | 85 | |
| 19 | 25 | |
| 20 | 1 |
About Erika Borlenghi
Erika Borlenghi is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 59 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (26 papers), Acute Lymphoblastic Leukemia research (20 papers) and Chronic Myeloid Leukemia Treatments (15 papers). The work is most often cited by research in Hematology (491 citations), Geriatrics and Gerontology (103 citations) and Genetics (216 citations). Erika Borlenghi has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Giuseppe Rossi, Chiara Cattaneo, Alessandra Tucci, Alessandro Re, Chiara Bottelli, Salvatore Casari, Monica Drera, Samantha Ferrari, Chiara Pagani and Angela Passi. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.